Huda Zoghbi is a Howard Hughes Medical Institute investigator and professor of molecular and human genetics at Baylor College of Medicine in Houston, Texas. She is also director of the Jan and Dan Duncan Neurological Research Institute. Zoghbi explores the biology of genetic disorders such as Rett syndrome, and the genes essential for normal neurodevelopment.
Huda Zoghbi
Professor
Baylor College of Medicine
From this contributor
Remembering Steve Warren (1953-2021): A giant in the field of genetics
Steve Warren co-discovered the genetic mechanism that underpins fragile X syndrome and was a generous, inspiring mentor to many.
Remembering Steve Warren (1953-2021): A giant in the field of genetics
Questions for Huda Zoghbi: Studying Rett in the rodent brain
Removing the Rett syndrome gene, MeCP2, from distinct cells and brain regions reveals hidden features of the condition.
Questions for Huda Zoghbi: Studying Rett in the rodent brain
Explore more from The Transmitter
The Transmitter’s most-read neuroscience book excerpts of 2025
Books by Nachum Ulanovsky, Nicole Rust, and Andrew Iwaniuk and Georg Striedter made the list of some of the year's most engaging neuroscience titles.
The Transmitter’s most-read neuroscience book excerpts of 2025
Books by Nachum Ulanovsky, Nicole Rust, and Andrew Iwaniuk and Georg Striedter made the list of some of the year's most engaging neuroscience titles.
Neuroscience’s leaders, legacies and rising stars of 2025
Here are seven stories from the past year about some of the field’s most engaging figures.
Neuroscience’s leaders, legacies and rising stars of 2025
Here are seven stories from the past year about some of the field’s most engaging figures.
The Transmitter’s top news articles of 2025
Check out some of our most-read stories, covering neuroscience funding and policy changes in the United States, and methodological issues in high-profile neuroscience papers.
The Transmitter’s top news articles of 2025
Check out some of our most-read stories, covering neuroscience funding and policy changes in the United States, and methodological issues in high-profile neuroscience papers.